184 related articles for article (PubMed ID: 9153803)
1. Stereotactic large-gauge core biopsy: its role in the diagnosis of non-palpable mammographic abnormalities presenting to a screening service.
Sutton S; Dahlstrom JE; Jain S
Australas Radiol; 1997 May; 41(2):103-8. PubMed ID: 9153803
[TBL] [Abstract][Full Text] [Related]
2. [Results of stereotactic breast biopsy in mammographically suspicious lesions].
Jäger HJ; Schatz TH; Mehring UM; Kubasch M; Hennigs S; Gissler HM; Spörl HD; Mathias KD
Rofo; 2000 Apr; 172(4):346-53. PubMed ID: 10961219
[TBL] [Abstract][Full Text] [Related]
3. Stereotactic core needle biopsy of nonpalpable breast lesions: initial experience with a promising technique.
Seoudi H; Mortier J; Basile R; Curletti E
Arch Surg; 1998 Apr; 133(4):366-72. PubMed ID: 9565115
[TBL] [Abstract][Full Text] [Related]
4. False-negative diagnoses at stereotactic vacuum-assisted needle breast biopsy: long-term follow-up of 1,280 lesions and review of the literature.
Jackman RJ; Marzoni FA; Rosenberg J
AJR Am J Roentgenol; 2009 Feb; 192(2):341-51. PubMed ID: 19155393
[TBL] [Abstract][Full Text] [Related]
5. Stereotactic, automated, large-core needle biopsy of nonpalpable breast lesions: false-negative and histologic underestimation rates after long-term follow-up.
Jackman RJ; Nowels KW; Rodriguez-Soto J; Marzoni FA; Finkelstein SI; Shepard MJ
Radiology; 1999 Mar; 210(3):799-805. PubMed ID: 10207484
[TBL] [Abstract][Full Text] [Related]
6. Follow-up of breast lesions diagnosed as benign with stereotactic core-needle biopsy: frequency of mammographic change and false-negative rate.
Lee CH; Philpotts LE; Horvath LJ; Tocino I
Radiology; 1999 Jul; 212(1):189-94. PubMed ID: 10405741
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic accuracy of stereotactic core biopsy in a mammographic breast cancer screening programme.
Dahlstrom JE; Jain S; Sutton T; Sutton S
Histopathology; 1996 May; 28(5):421-7. PubMed ID: 8735717
[TBL] [Abstract][Full Text] [Related]
8. Non-palpable mammographic abnormalities.
Aitken RJ; Chetty U
J R Coll Surg Edinb; 1991 Dec; 36(6):362-71. PubMed ID: 1774703
[TBL] [Abstract][Full Text] [Related]
9. Stereotactic core-needle biopsy of non-mass calcifications: outcome and accuracy at long-term follow-up.
Han BK; Choe YH; Ko YH; Nam SJ; Kim JH; Yang JH
Korean J Radiol; 2003; 4(4):217-23. PubMed ID: 14726638
[TBL] [Abstract][Full Text] [Related]
10. Breast cancer detection with short-interval follow-up compared with return to annual screening in patients with benign stereotactic or US-guided breast biopsy results.
Johnson JM; Johnson AK; O'Meara ES; Miglioretti DL; Geller BM; Hotaling EN; Herschorn SD
Radiology; 2015 Apr; 275(1):54-60. PubMed ID: 25423143
[TBL] [Abstract][Full Text] [Related]
11. Add-on device for stereotactic core-needle breast biopsy: how many biopsy specimens are needed for a reliable diagnosis?
Koskela AK; Sudah M; Berg MH; Kärjä VJ; Mustonen PK; Kataja V; Vanninen RS
Radiology; 2005 Sep; 236(3):801-9. PubMed ID: 16020555
[TBL] [Abstract][Full Text] [Related]
12. Stereotactic fine needle aspiration in the management of mammographic abnormalities detected in breast screening.
Chan MC; Lam HS; Gwi E; Leung TY; Lau Y; Yip WC
Aust N Z J Surg; 1996 Sep; 66(9):595-7. PubMed ID: 8859157
[TBL] [Abstract][Full Text] [Related]
13. Stereotactic core needle biopsy of nonpalpable breast lesions using a conventional mammography unit with an add-on device.
Kirshenbaum KJ; Voruganti T; Overbeeke C; Kirshenbaum MD; Patel P; Kaplan G; Maker V; August C; Cavallino RP
AJR Am J Roentgenol; 2003 Aug; 181(2):527-31. PubMed ID: 12876040
[TBL] [Abstract][Full Text] [Related]
14. Stereotactic 14G core biopsy of non-palpable breast cancer: what is the relationship between the number of core samples taken and the sensitivity for detection of malignancy?
Rich PM; Michell MJ; Humphreys S; Howes GP; Nunnerley HB
Clin Radiol; 1999 Jun; 54(6):384-9. PubMed ID: 10406340
[TBL] [Abstract][Full Text] [Related]
15. Stereotactic core needle breast biopsy is an accurate diagnostic technique to assess nonpalpable mammographic abnormalities.
Fuhrman G; Cederbom G; Champagne J; Farr G; McKinnon W; Bolton J; Ordoyne WK
J La State Med Soc; 1996 Apr; 148(4):167-70. PubMed ID: 8935619
[TBL] [Abstract][Full Text] [Related]
16. Role of stereotactic breast biopsy.
Bernstein JR
Semin Surg Oncol; 1996; 12(5):290-9. PubMed ID: 8873316
[TBL] [Abstract][Full Text] [Related]
17. Percutaneous removal of benign mammographic lesions: comparison of automated large-core and directional vacuum-assisted stereotactic biopsy techniques.
Jackman RJ; Marzoni FA; Nowels KW
AJR Am J Roentgenol; 1998 Nov; 171(5):1325-30. PubMed ID: 9798873
[TBL] [Abstract][Full Text] [Related]
18. Stereotactic core needle biopsy of mammographic breast lesions as a viable alternative to surgical biopsy.
Mikhail RA; Nathan RC; Weiss M; Tummala RM; Mullangi UR; Lawrence L; Mukkamala A
Ann Surg Oncol; 1994 Sep; 1(5):363-7. PubMed ID: 7850536
[TBL] [Abstract][Full Text] [Related]
19. Underestimation of the presence of breast carcinoma in papillary lesions initially diagnosed at core-needle biopsy.
Sydnor MK; Wilson JD; Hijaz TA; Massey HD; Shaw de Paredes ES
Radiology; 2007 Jan; 242(1):58-62. PubMed ID: 17090707
[TBL] [Abstract][Full Text] [Related]
20. Mammography-guided stereotactic fine-needle aspiration cytology of nonpalpable breast lesions: prospective comparison with surgical biopsy results.
Fajardo LL; Davis JR; Wiens JL; Trego DC
AJR Am J Roentgenol; 1990 Nov; 155(5):977-81. PubMed ID: 2120967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
